| Original language | English (US) |
|---|---|
| Pages (from-to) | 158-161 |
| Number of pages | 4 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 86 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2022 |
Funding
Funding sources: This project was funded by unrestricted educational grants from Sun Pharmaceuticals and the Foundation for Ichthyosis and Related Skin Types . Administrative support was provided by the Pediatric Dermatology Research Alliance . Dr Zaenglein is or has been an investigator for AbbVie, Incyte, Pfizer, Sun Pharmaceuticals; on the advisory board for Cassiopea and Verrica; a consultant for Pfizer and Sun Pharmaceuticals; Editor-in-Chief for Pediatric Dermatology; and an author for UptoDate. Dr Levy is or has been an investigator for Fibrocell, Galderma, Janssen, Pfizer; a consultant for Cassiopea, Regeneron, and UCB; on the advisory board for Cassiopea, Regeneron, and UCB; a section editor and author for UptoDate; and data and safety monitoring board for Novan. Dr Benjamin is or has been a consultant for Dove, Mustela, CeraVe, La Roche-Posay; on the advisory board for Mustela, CeraVe, La Roche-Posay, Bioderma, Cutanea, Biofrontera, Menlo Therapeutics, and Pfizer; on the speakers bureau for Regeneron and Sanofi-Genzyme, and an author for UptoDate. Dr Bruckner is or has been an investigator for Mayne Pharma. Dr Choate is or has been on the advisory board for AbbVie and Janssen; a speaker for Abbvie and Janssen; a consultant for Mayne Pharma and Timber Pharmaceuticals; an investigator for Mayne Pharma; and an author for UptoDate. Dr Craiglow is or has been on the advisory board for Aclaris, Arena Pharmaceuticals, and Pfizer; a consultant for Aclaris, Concert Pharmaceuticals, and Pfizer; and a speaker for Pfizer, Regeneron, and Sanofi-Genzyme. Dr Eichenfield is or has been an investigator for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; a consultant for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; on the advisory board for Cassiopea; and an author for UptoDate. Dr Lawley is or has been an author for UptoDate. Dr Mathes is or has been a consultant for Aldeyra Therapeutics, Rodan+Fields, and Pierre Fabre and an author for UptoDate. Dr Paller is or has been an investigator for AbbVie, Anaptysbio, Celgene, Castle Creek, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron and a consultant for Almirall, Amgen, Asana, Boehringer-Ingelheim, Castle Creek, Dermavant, Dermira, Exicure, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Pfizer, and Regeneron, Sanofi-Genzyme, and Sol Gel. Dr Siegel is or has been a consultant for Arqule, an author for UptoDate, and has received a research grant from Sun Pharmaceuticals. Dr Tanumihardjo is or has been on an expert panel for the World Health Organization. Drs Stefanko, DiGiovanna, Elias, Fleckman, Lewis, Lucky, Milstone, Patel, Teng, Thaxton, and Williams have no conflicts of interest to declare.
ASJC Scopus subject areas
- Dermatology